Literature DB >> 23129554

Ubiquitin-proteasome system impairment and MPTP-induced oxidative stress in the brain of C57BL/6 wild-type and GSTP knockout mice.

Andreia Neves Carvalho1, Carla Marques, Elsa Rodrigues, Colin J Henderson, C Roland Wolf, Paulo Pereira, Maria João Gama.   

Abstract

The ubiquitin-proteasome system (UPS) is the primary proteolytic complex responsible for the elimination of damaged and misfolded intracellular proteins, often formed upon oxidative stress. Parkinson's disease (PD) is neuropathologically characterized by selective death of dopaminergic neurons in the substantia nigra (SN) and accumulation of intracytoplasmic inclusions of aggregated proteins. Along with mitochondrial dysfunction and oxidative stress, defects in the UPS have been implicated in PD. Glutathione S-transferase pi (GSTP) is a phase II detoxifying enzyme displaying important defensive roles against the accumulation of reactive metabolites that potentiate the aggression of SN neuronal cells, by regulating several processes including S-glutathionylation, modulation of glutathione levels and control of kinase-catalytic activities. In this work we used C57BL/6 wild-type and GSTP knockout mice to elucidate the effect of both MPTP and MG132 in the UPS function and to clarify if the absence of GSTP alters the response of this pathway to the neurotoxin and proteasome inhibitor insults. Our results demonstrate that different components of the UPS have different susceptibilities to oxidative stress. Importantly, when compared to the wild-type, GSTP knockout mice display decreased ubiquitination capacity and overall increased susceptibility to UPS damage and inactivation upon MPTP-induced oxidative stress.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23129554     DOI: 10.1007/s12035-012-8368-4

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  48 in total

1.  Glutathione S-transferase P1-1 (GSTP1-1) inhibits c-Jun N-terminal kinase (JNK1) signaling through interaction with the C terminus.

Authors:  T Wang; P Arifoglu; Z Ronai; K D Tew
Journal:  J Biol Chem       Date:  2001-03-09       Impact factor: 5.157

2.  Brain proteasomal function in sporadic Parkinson's disease and related disorders.

Authors:  Yoshiaki Furukawa; Sophie Vigouroux; Henry Wong; Mark Guttman; Ali H Rajput; Lee Ang; Marièle Briand; Stephen J Kish; Yves Briand
Journal:  Ann Neurol       Date:  2002-06       Impact factor: 10.422

3.  Glutathione S-transferase pi mediates MPTP-induced c-Jun N-terminal kinase activation in the nigrostriatal pathway.

Authors:  Margarida Castro-Caldas; Andreia Neves Carvalho; Elsa Rodrigues; Colin Henderson; C Roland Wolf; Maria João Gama
Journal:  Mol Neurobiol       Date:  2012-04-27       Impact factor: 5.590

4.  The ubiquitin pathway in Parkinson's disease.

Authors:  E Leroy; R Boyer; G Auburger; B Leube; G Ulm; E Mezey; G Harta; M J Brownstein; S Jonnalagada; T Chernova; A Dehejia; C Lavedan; T Gasser; P J Steinbach; K D Wilkinson; M H Polymeropoulos
Journal:  Nature       Date:  1998-10-01       Impact factor: 49.962

5.  Oxidative stress and recovery from oxidative stress are associated with altered ubiquitin conjugating and proteolytic activities in bovine lens epithelial cells.

Authors:  F Shang; A Taylor
Journal:  Biochem J       Date:  1995-04-01       Impact factor: 3.857

6.  Proposed role of ATP in protein breakdown: conjugation of protein with multiple chains of the polypeptide of ATP-dependent proteolysis.

Authors:  A Hershko; A Ciechanover; H Heller; A L Haas; I A Rose
Journal:  Proc Natl Acad Sci U S A       Date:  1980-04       Impact factor: 11.205

7.  Functional heterogeneity of ubiquitin carrier proteins.

Authors:  C M Pickart; I A Rose
Journal:  J Biol Chem       Date:  1985-02-10       Impact factor: 5.157

Review 8.  Glutathione transferases.

Authors:  John D Hayes; Jack U Flanagan; Ian R Jowsey
Journal:  Annu Rev Pharmacol Toxicol       Date:  2005       Impact factor: 13.820

9.  Components of ubiquitin-protein ligase system. Resolution, affinity purification, and role in protein breakdown.

Authors:  A Hershko; H Heller; S Elias; A Ciechanover
Journal:  J Biol Chem       Date:  1983-07-10       Impact factor: 5.157

10.  Fine structure and biochemical mechanisms underlying nigrostriatal inclusions and cell death after proteasome inhibition.

Authors:  Francesco Fornai; Paola Lenzi; Marco Gesi; Michela Ferrucci; Gloria Lazzeri; Carla L Busceti; Riccardo Ruffoli; Paola Soldani; Stefano Ruggieri; Maria G Alessandri; Antonio Paparelli
Journal:  J Neurosci       Date:  2003-10-01       Impact factor: 6.167

View more
  6 in total

1.  Inhibition of Protein Ubiquitination by Paraquat and 1-Methyl-4-Phenylpyridinium Impairs Ubiquitin-Dependent Protein Degradation Pathways.

Authors:  Juliana Navarro-Yepes; Annadurai Anandhan; Erin Bradley; Iryna Bohovych; Bo Yarabe; Annemieke de Jong; Huib Ovaa; You Zhou; Oleh Khalimonchuk; Betzabet Quintanilla-Vega; Rodrigo Franco
Journal:  Mol Neurobiol       Date:  2015-09-26       Impact factor: 5.590

Review 2.  Glutathione metabolism and Parkinson's disease.

Authors:  Michelle Smeyne; Richard Jay Smeyne
Journal:  Free Radic Biol Med       Date:  2013-05-08       Impact factor: 7.376

Review 3.  The Dietary Components Carnosic Acid and Carnosol as Neuroprotective Agents: a Mechanistic View.

Authors:  Marcos Roberto de Oliveira
Journal:  Mol Neurobiol       Date:  2015-11-09       Impact factor: 5.590

4.  A Proteomic Approach to Uncover Neuroprotective Mechanisms of Oleocanthal against Oxidative Stress.

Authors:  Laura Giusti; Cristina Angeloni; Maria Cristina Barbalace; Serena Lacerenza; Federica Ciregia; Maurizio Ronci; Andrea Urbani; Clementina Manera; Maria Digiacomo; Marco Macchia; Maria Rosa Mazzoni; Antonio Lucacchini; Silvana Hrelia
Journal:  Int J Mol Sci       Date:  2018-08-08       Impact factor: 5.923

5.  CaV1.3 L-Type Calcium Channels Increase the Vulnerability of Substantia Nigra Dopaminergic Neurons in MPTP Mouse Model of Parkinson's Disease.

Authors:  Aditi Verma; Vijayalakshmi Ravindranath
Journal:  Front Aging Neurosci       Date:  2020-01-17       Impact factor: 5.750

6.  Bortezomib alleviates drug-induced liver injury by regulating CYP2E1 gene transcription.

Authors:  Woo-Jae Park; So-Yeon Kim; Ye-Ryung Kim; Joo-Won Park
Journal:  Int J Mol Med       Date:  2016-01-20       Impact factor: 4.101

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.